Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients

Internal and Emergency Medicine

Volumn 7, Issue 3, 2012, Pages 257-266

  Gazzaruso, Carmine ^a   Coppola, Adriana ^a   Montalcini, Tiziana ^b   Valenti, Cinzia ^c   Pelissero, Gabriele ^a   Solerte, Sebastiano Bruno ^d   Salvucci, Fabrizio ^e   Gallotti, Pietro ^a   Pujia, Arturo ^b   Garzaniti, Adriana ^f   Giustina, Andrea ^g  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c Cardiology Unit   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e Cardiology Unit   (Italy)

^f Diabetes Centre   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cardiovascular prognosis; Diabetes; Screening; Silent coronary artery disease

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; FEMALE; HUMAN; ITALY; KAPLAN MEIER METHOD; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPARAMETRIC TEST; PATHOLOGY; PROGNOSIS; STATISTICS; TIME;

CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MASS SCREENING; MIDDLE AGED; PROGNOSIS; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84862185592     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0527-5     Document Type: Article

References (39)

1. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO Multinational Study of vascular diseases in diabetes. Diabetologia 44: S14-S21.
2. Hammoud T, Tanguay JF, Bourassa MG (2000) Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 36: 355-365.
3. Gazzaruso C (2005) Erectile dysfunction and silent myocardial ischemia. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds) Harrison's Principles of internal medicine, 16th edn. McGraw Hill Medical, New York, NY (1/13/2005 update online).
4. Koistinen MJ (1990) Prevalence of asymptomatic myocardial ischemia in diabetic subjects. BMJ 301: 92-95.
5. Lorusso R, Pentiricci S, Raddino R, Scarabelli TM, Zambelli C, Villanacci V, Burattin A, Romalelli G, Casari S, Scelsi R, Giustina A (2003) Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. Diabetes 52: 2814-2820.
6. Jouven X, Lemaitre RN, Rea TD, Sotoodehnia N, Empana JP, Siscovick DS (2005) Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J 26: 2142-2147.
7. Huxley R, Barzi F, Woodward M (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332: 73-78.
8. Smith JW, Marcus FI, Serokman R (1984) Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 54: 718-721.
9. Adult treatment panel III (2001) Executive summary of the third report of the national cholesterol education program (NCEP) Expert panel of detection evaluation, and treatment of high blood cholesterol in adults. JAMA 285: 2486-2497.
10. Haffner SM, Lehto S, Ronnemaa T (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234.
11. Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C (2008) Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3. 3 million people. Circulation 117: 1945-1954.
12. American Diabetes Association (1998) Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21: 1551-1559.
13. Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ, For the American Diabetes Association (2007) Screening for coronary artery disease in patients with diabetes. Diabetes Care 30: 2729-2736.
14. Gibbsons RJ (2006) Asymptomatic patients with diabetes mellitus should not be screened for coronary artery disease. J Nucl Cardiol 13: 616-620.
15. Wackers FJT (2006) Asymptomatic patients with diabetes mellitus should be screened for coronary artery disease. J Nucl Cardiol 13: 609-615.
16. Miller TD, Redberg RF, Wackers FJT (2006) Screening asymptomatic diabetic patients for coronary artery disease. Why not? J Am Coll Cardiol 48: 761-764.
17. Beller GA (2007) Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients. Is it appropriate and cost-effective? J Am Coll Cardiol 49: 1918-1923.
18. Faglia E, Mantero M, Quarantiello A, Gino M, Curci V, Caminiti M, Mattioli R, Morabito A (2005) Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am Heart J 149: e1-e6.
19. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Heller GV, Iskandrian AE, Wittlin SD, Filipchuk N, Ratner RE, Inzucchi SE, DIAD Investigators (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD study: a randomized controlled trial. JAMA 301: 1547-1555.
20. Cohn PF (1988) Silent myocardial ischemia. Ann Intern Med 109: 312-317.
21. Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, Valenti C, Giustina A, Garzaniti A (2008) Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with asymptomatic coronary artery disease angiographically proven. A potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 51: 2040-2044.
22. Gazzaruso C, Pujia A, Solerte SB, Amici ED, Emanuele E, Falcone C, Geroldi D, Giustina A, Garzaniti A (2006) Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients. Int J Impot Res 18: 311-315.
23. The Expert Committee on the diagnosis and classification of diabetes mellitus (1997) Report of the Expert Committee on the Diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183-1197.
24. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A; ESH-ESC Task Force on the Management of Arterial Hypertension (2007) ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25(9): 1751-1762.
25. Giustina A, Perini P, Desenzani P, Bossoni S, Ianniello P, Milani M, Davì G, Romanelli G (1998) Long-term treatment with the dual antithrombotic agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients. Diabetes 47: 423-430.
26. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, Fratino P (2002) Silent coronary artery disease in type 2 diabetes mellitus: the role of lipoprotein(a), homocysteine and apo(a) polymorphism. Cardiovasc Diabetol 1: 5.
27. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
28. Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A (2004) Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110: 22-26.
29. Gazzaruso C, Solerte SB, De Amici E, Mancini M, Pujia A, Fratino P, Giustina A, Garzaniti A (2006) Association of the metabolic syndrome and insulin-resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus. Am J Cardiol 97: 236-239.
30. Choi EK, Koo BK, Kim HS, Cho YM, Kang HJ, Cho YS, Chung WY, Chae IH, Choi DJ, Oh BH, Park YB, Choi YS (2007) Prognostic significance of asymptomatic coronary artery disease in patients with diabetes and need for early revascularization therapy. Diab Med 24: 1003-1011.
31. Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S, Sopko G, Ramires JA, Schneider D, Frye RL, Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group (2009) The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 120: 2529-2540.
32. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association, National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Statement. Circulation 112: 2735-2752.
33. Martin JH, Mangiafico S, Kelly DJ (2009) Role of statins in diabetes complications. Curr Diab Rev 5: 165-170.
34. Albers AR, Krichavsky MZ, Balady GJ (2006) Stress testing in patients with diabetes. Diagnostic and prognostic value. Circulation 113: 583-592.
35. Barthelemy O, Le Fevre C, Timsit J (2007) Silent myocardial ischemia screening in patients with diabetes mellitus. Arq Bras Endocrinol Metab 51(2): 285-293.
36. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE, Detection of Ischemia in Asymptomatic Diabetics Investigators (2004) Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27: 1954-1961.
37. Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A (2006) Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47: 65-71.
38. Poulsen MK, Henriksen JE, Vach W, Dahl J, Møller JE, Johansen A, Gerke O, Haghfelt T, Høilund-Carlsen PF, Beck-Nielsen H (2010) Identification of asymptomatic type 2 diabetes mellitus patients with a low, intermediate and high risk of ischemic heart disease: is there an algorithm? Diabetologia 53: 659-667.
39. Turrini F, Messora R, Giovanardi P, Tondi S, Magnavacchi P, Cavani R, Tosoni G, Cappelli C, Pellegrini E, Romano S, Baldini A, Zennaro RG, Bondi M (2009) Screening asymptomatic patients with diabetes for unknown coronary artery disease: does it reduce risk? An open-label randomized trial comparing a strategy based on exercise testing aimed at revascularization with management based on pharmacological/behavioural treatment of traditional risk factors. DADDY-D trial Does coronary Atherosclerosis Deserve to be Diagnosed and treated early in Diabetics?. Trial 10: 119.